Robert Taub Robert
board of director
Taub has been an entrepreneur in the biopharmaceutical and medical technology fields for more than four decades. He is an investor and co-founder/ founder of life science companies worldwide, including in Israel. More recently, in 2009, he co-founded Nyxoah S.A, an implantable device company to treat obstructive sleep apnea. In 1995, he founded and served as the chief executive officer, president and director at Omrix Biopharmaceuticals, Inc. where he led the company’s April 2006 NASDAQ IPO and eventual sale to ETHICON, Johnson and Johnson in December 2008 for $432 million. In 1983 Mr. Taub co-founded Octapharma, a Swiss plasma fractionation and pharmaceutical company, which successfully introduced innovative plasma derivative products to the market. He co-managed the company until 1995. Robert Taub has made several investments in the biotech/MEDTECH sector taking an active board position in most cases. In particular, he is currently the executive chairman of Neuroderm ltd., a company developing products to treat Parkinson’s and other neuro-degenerative diseases. Robert Taub holds a B.A. in languages from the University of Antwerp and an M.B.A. from INSEAD (the European Institute of Business Administration) in Fontainebleau, France.